KLDO vs. PHXM, NMTR, PTEIQ, HGEN, ATNFW, SXTPW, DRTSW, APLMW, ARTLW, and BCDAW
Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include PHAXIAM Therapeutics (PHXM), 9 Meters Biopharma (NMTR), PolarityTE (PTEIQ), Humanigen (HGEN), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), and BioCardia (BCDAW). These companies are all part of the "biotechnology" industry.
PHAXIAM Therapeutics (NASDAQ:PHXM) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, community ranking, dividends, valuation and analyst recommendations.
PHAXIAM Therapeutics has a beta of 2.35, suggesting that its share price is 135% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500.
In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled PHAXIAM Therapeutics'average media sentiment score.
PHAXIAM Therapeutics has higher revenue and earnings than Kaleido Biosciences.
0.4% of PHAXIAM Therapeutics shares are owned by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are owned by institutional investors. 1.9% of PHAXIAM Therapeutics shares are owned by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Kaleido Biosciences received 54 more outperform votes than PHAXIAM Therapeutics when rated by MarketBeat users.
Summary
PHAXIAM Therapeutics and Kaleido Biosciences tied by winning 3 of the 6 factors compared between the two stocks.
Get Kaleido Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kaleido Biosciences Competitors List
Related Companies and Tools
